Autor: "The IMPACT Study Steering Committee and Collaborators" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Autorzy:: Minh-Phuong Huynh-Le
Chun Chieh Fan
Roshan Karunamuni
Wesley K. Thompson
Maria Elena Martinez
Rosalind A. Eeles
Zsofia Kote-Jarai
Kenneth Muir
Johanna Schleutker
Nora Pashayan
Jyotsna Batra
Henrik Grönberg
David E. Neal
Jenny L. Donovan
Freddie C. Hamdy
Richard M. Martin
Sune F. Nielsen
Børge G. Nordestgaard
Fredrik Wiklund
Catherine M. Tangen
Graham G. Giles
Alicja Wolk
Demetrius Albanes
Ruth C. Travis
William J. Blot
Wei Zheng
Maureen Sanderson
Janet L. Stanford
Lorelei A. Mucci
Catharine M. L. West
Adam S. Kibel
Olivier Cussenot
Sonja I. Berndt
Stella Koutros
Karina Dalsgaard Sørensen
Cezary Cybulski
Eli Marie Grindedal
Florence Menegaux
Kay-Tee Khaw
Jong Y. Park
Sue A. Ingles
Christiane Maier
Robert J. Hamilton
Stephen N. Thibodeau
Barry S. Rosenstein
Yong-Jie Lu
Stephen Watya
Ana Vega
Manolis Kogevinas
Kathryn L. Penney
Chad Huff
Manuel R. Teixeira
Luc Multigner
Robin J. Leach
Lisa Cannon-Albright
Hermann Brenner
Esther M. John
Radka Kaneva
Christopher J. Logothetis
Susan L. Neuhausen
Kim De Ruyck
Hardev Pandha
Azad Razack
Lisa F. Newcomb
Jay H. Fowke
Marija Gamulin
Nawaid Usmani
Frank Claessens
Manuela Gago-Dominguez
Paul A. Townsend
William S. Bush
Monique J. Roobol
Marie-Élise Parent
Jennifer J. Hu
Ian G. Mills
Ole A. Andreassen
Anders M. Dale
Tyler M. Seibert
UKGPCS collaborators
APCB (Australian Prostate Cancer BioResource)
NC-LA PCaP Investigators
The IMPACT Study Steering Committee and Collaborators
Canary PASS Investigators
The Profile Study Steering Committee
The PRACTICAL Consortium; Pokaż więcej
Temat:: Science
Źródło:: Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Opis pliku:: electronic resource
Relacje:: https://doaj.org/toc/2041-1723
Dostęp URL:: https://doaj.org/article/2acc58dd13bb4c07abb40966fce96b6f Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
Autorzy:: Andreia Brandão
Paula Paulo
Sofia Maia
Manuela Pinheiro
Ana Peixoto
Marta Cardoso
Maria P. Silva
Catarina Santos
Rosalind A. Eeles
Zsofia Kote-Jarai
Kenneth Muir
UKGPCS Collaborators
Johanna Schleutker
Ying Wang
Nora Pashayan
Jyotsna Batra
APCB BioResource
Henrik Grönberg
David E. Neal
Børge G. Nordestgaard
Catherine M. Tangen
Melissa C. Southey
Alicja Wolk
Demetrius Albanes
Christopher A. Haiman
Ruth C. Travis
Janet L. Stanford
Lorelei A. Mucci
Catharine M. L. West
Sune F. Nielsen
Adam S. Kibel
Olivier Cussenot
Sonja I. Berndt
Stella Koutros
Karina Dalsgaard Sørensen
Cezary Cybulski
Eli Marie Grindedal
Jong Y. Park
Sue A. Ingles
Christiane Maier
Robert J. Hamilton
Barry S. Rosenstein
Ana Vega
The IMPACT Study Steering Committee and Collaborators
Manolis Kogevinas
Fredrik Wiklund
Kathryn L. Penney
Hermann Brenner
Esther M. John
Radka Kaneva
Christopher J. Logothetis
Susan L. Neuhausen
Kim De Ruyck
Azad Razack
Lisa F. Newcomb
Canary PASS Investigators
Davor Lessel
Nawaid Usmani
Frank Claessens
Manuela Gago-Dominguez
Paul A. Townsend
Monique J. Roobol
The Profile Study Steering Committee
The PRACTICAL Consortium
Manuel R. Teixeira; Pokaż więcej
Temat:: prostate cancer
founder variant
CHEK2
cancer predisposition
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:: Cancers, Vol 12, Iss 11, p 3254 (2020)
Opis pliku:: electronic resource
Relacje:: https://www.mdpi.com/2072-6694/12/11/3254; https://doaj.org/toc/2072-6694
Dostęp URL:: https://doaj.org/article/c42a00ab731c4ddf9d49e69ae9894869 Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.
Autorzy:: Brandão A; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Paulo P; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Maia S; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Pinheiro M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Peixoto A; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Cardoso M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Silva MP; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Santos C; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Eeles RA; The Institute of Cancer Research, London SM2 5NG, UK.; Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
Kote-Jarai Z; The Institute of Cancer Research, London SM2 5NG, UK.
Muir K; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester M13 9PL, UK.; Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
Ukgpcs Collaborators; The Institute of Cancer Research, London SW7 3RP, UK.
Schleutker J; Institute of Biomedicine, University of Turku, FI-20014 Turun Yliopisto, 20050 Turku, Finland.; Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, P.O. Box 52, 20521 Turku, Finland.
Wang Y; Department of Population Science, American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA.
Pashayan N; Department of Applied Health Research, University College London, London WC1E 7HB, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
Batra J; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.; Translational Research Institute, Brisbane, QLD 4102, Australia.
Apcb BioResource; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.; Translational Research Institute, Brisbane, QLD 4102, Australia.
Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden.
Neal DE; Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
Nordestgaard BG; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark.
Tangen CM; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M3-C102, Seattle, WA 98109-1024, USA.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC 3004, Australia.; Department of Clinical Pathology, The Melbourne Medical School, The University of Melbourne, Melbourne, VIC 3004, Australia.
Wolk A; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.; Department of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden.
Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
Haiman CA; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA.
Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, DC 98109-1024, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, DC 98195, USA.
Mucci LA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
West CML; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester M13 9PL, UK.
Nielsen SF; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark.
Kibel AS; Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA 02115, USA.
Cussenot O; Sorbonne Universite, GRC n 5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-75020 Paris, France.; CeRePP, Tenon Hospital, F-75020 Paris, France.
Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
Sørensen KD; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensen Boulevard 99, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, DK-8200 Aarhus N, Denmark.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland.
Grindedal EM; Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway.
Park JY; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Ingles SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA.
Maier C; Humangenetik Tuebingen, Paul-Ehrlich-Str 23, D-72076 Tuebingen, Germany.
Hamilton RJ; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Surgery (Urology), University of Toronto, Toronto, ON M5T 1P5, Canada.
Rosenstein BS; Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Box 1236, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674, USA.
Vega A; Fundación Pública Galega Medicina Xenómica, 15706 Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago De Compostela, Spain.; CIBER of Rare Diseases (CIBERER), 28029 Madrid, Spain.
The Impact Study Steering Committee And Collaborators; The Institute of Cancer Research, London SW7 3RP, UK.
Kogevinas M; ISGlobal, 08036 Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.; Campus del Mar, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Wiklund F; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden.
Penney KL; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02184, USA.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
John EM; Departments of Epidemiology & Population Health and of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94304, USA.
Kaneva R; Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.
Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.
Ruyck K; Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Proeftuinstraat 86, 9000 Gent, Belgium.
Razack A; Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Newcomb LF; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, DC 98109-1024, USA.; Department of Urology, University of Washington, 1959 NE Pacific Street, Box 356510, Seattle, WA 98195, USA.
Canary Pass Investigators; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, DC 98109-1024, USA.; Department of Urology, University of Washington, 1959 NE Pacific Street, Box 356510, Seattle, WA 98195, USA.
Lessel D; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Usmani N; Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.; Division of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.
Claessens F; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, Campus Gasthuisberg, University of Leuven, Herestraat 49, P.O. Box 901, 3000 Leuven, Belgium.
Gago-Dominguez M; Group of Genomic Medicine, Galician Public Foundation of Genomic Medicine, Health Research Institute of Santiago de Compostela (IDIS), Galician Healthcare Service (SERGAS) University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Moores Cancer Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093-0012, USA.
Townsend PA; Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester M13 9PL, UK.
Roobol MJ; Department of Urology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands.
The Profile Study Steering Committee; Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK.
The Practical Consortium
Teixeira MR; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.; Biomedical Sciences Institute Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2020 Nov 04; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 04.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""The IMPACT Study Steering Committee and Collaborators"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język